Gene silencing showed an important role of mda-9/syntenin in UM cell migration, invasion, and FAK activation, suggesting that mda-9/syntenin is involved in uveal melanoma progression and may represent a potential therapeutic target [102]. Here, SDCBP is linked to uveal melanoma.